Comparing the measurement properties of the EQ-5D-5 L, SF-6Dv2, QLU-C10D and FACT-8D among survivors of classical Hodgkin’s lymphoma
EQ-5D-5 L outperformed SF-6Dv2 in terms of agreement with cancer-specific PRMs and discriminant ability. However, SF-6Dv2 showed stronger associations with similar dimensions of QLU-C10D and FACT-8D, indicating high convergent validity. The generic PBMs are sensitive enough to measure HRQoL in survivors of CHL.
Authors
- A Monteiro (ORCID: https://orcid.org/0000-0001-9763-3485)
- Tianxin Pan (ORCID: https://orcid.org/0000-0002-2243-8818)
- Hongfei Gu (ORCID: https://orcid.org/0000-0001-7976-0341)
- Richard Huan Xu (ORCID: https://orcid.org/0000-0002-4720-5172)
- Zuyi Zhao
- Dong Dong (ORCID: https://orcid.org/0000-0001-9784-6472)
Institutions
- Hong Kong Polytechnic University (HK)
- The University of Melbourne (AU)
- Chinese University of Hong Kong (HK)
- University of Illinois Chicago (US)
Publication Details
- Journal
- The European Journal of Health Economics
- Published
- 2024-10-17
- DOI
- https://doi.org/10.1007/s10198-024-01730-x
- Citations
- 5
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.12